Filter Results:
(422)
Show Results For
- All HBS Web
(635)
- People (4)
- News (110)
- Research (422)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Show Results For
- All HBS Web
(635)
- People (4)
- News (110)
- Research (422)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Sort by
- 20 Feb 2018
- First Look
First Look at New Research and Ideas, February 20, 2018
new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by... View Details
Keywords: Carmen Nobel
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
The first question focuses on motivations, while the second one has more to do with the benefits sought in interactions with future partners. Altruism As a general rule, collaboration efforts between companies and CSOs have an inherent... View Details
- 26 Apr 2011
- Op-Ed
HBS Faculty Comment on Environmental Issues for Earth Day
have been experimenting with integrated project delivery—a collaborative process that involves unprecedented teamwork and shared decision making throughout a design and building project. A number of companies are developing... View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
the negotiation. In April 2001, the FTC filed a complaint accusing pharmaceutical companies Schering-Plough and Upsher-Smith of restricting trade. Upsher-Smith had been preparing to introduce a generic View Details
Keywords: by Max H. Bazerman
- 03 Nov 2015
- First Look
November 3, 2015
quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to... View Details
Keywords: Sean Silverthorne
- 06 May 2008
- First Look
First Look: May 6, 2008
company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global... View Details
Keywords: Martha Lagace
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
executive branch and in Congress—who lacked the courage to risk political damage and take a stand on the issue. Sometimes, leaders actually set themselves up for predictable surprises. A classic example is the 1998 decision by a coalition of thirty-nine View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
Editor's Note. Given a veritable flood over the last year of corporate "inversions"—US companies that reincoporate in other countries to take advantage of favorable tax rates and business regulations—lawmakers in Washington D.C.... View Details
- 01 Dec 2003
- Research & Ideas
Sometimes Success Begins at Failure
in history. Most firms act as if false negatives don't exist because they don't have processes for managing them. In their own industries, many companies might have missed similar opportunities. Although smart organizations have... View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical View Details
Keywords: by Manda Salls
- 25 Jul 2005
- Research & Ideas
An Organization Your Customers Understand
pharmacy: a pharmaceutical company selling prescription drugs, and a consumer products company selling personal care products such as shampoo and beauty aids. A consumer... View Details
Keywords: by Robert Simons
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
717-426 Imprimis (A) This case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The (A) case provides a brief history of the View Details
Keywords: Sean Silverthorne
- 01 May 2007
- First Look
First Look: May 1, 2007
Business School Case 207-090 As part of its expansion and diversification strategy, the Chiaphua Group explored real estate investments in emerging markets. The Group was one of the largest privately held company groups based in Hong... View Details
Keywords: Sean Silverthorne
- 06 Feb 2007
- First Look
First Look: February 6, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=806092 Endo Pharmaceuticals (A): From LBO to...? Harvard Business School Case 806-064 Endo Pharmaceuticals was formed in 1997 as a leveraged... View Details
Keywords: Martha Lagace
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
infertility: eggs, sperm, and wombs. Sometimes, these components are sold along with IVF treatment—when a couple purchases eggs, for example, they are subsequently used for an IVF procedure—but they are often provided by individual brokers. Then there are the View Details
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
a vaccine to end the COVID-19 pandemic is Moderna, a Cambridge company with an immigrant co-founder and an immigrant CEO. Another firm already conducting vaccine trials is Inovio Pharmaceuticals of Plymouth... View Details
Keywords: by William R. Kerr
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
HarperBusiness in 2003].The book analyzes the impact of this remarkable family on one of the most important companies in the world. Chandler: I've completed my book on the chemical and pharmaceutical... View Details
Keywords: by Jim Aisner
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on... View Details